Loading…
Prevention of congenital syphilis within antenatal PrEP services in South Africa: missed opportunities
Syphilis in pregnancy and congenital syphilis are increasing globally, especially in locations with poor access to antenatal testing and due to global shortages of benzathine penicillin.3,4 In South Africa, the National Institute for Communicable Diseases (NICD) reported a steady increase in clinica...
Saved in:
Published in: | The Lancet infectious diseases 2024-06, Vol.24 (6), p.571-572 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Syphilis in pregnancy and congenital syphilis are increasing globally, especially in locations with poor access to antenatal testing and due to global shortages of benzathine penicillin.3,4 In South Africa, the National Institute for Communicable Diseases (NICD) reported a steady increase in clinical notifications of congenital syphilis cases and rapid plasma reagin-positive results in infants and children aged younger than 2 years between 2017 and 2020.5,6 Pregnant women are at increased risk of HIV acquisition and syphilis, and are a key population for HIV prevention through pre-exposure prophylaxis (PrEP) services.7,8 There is growing concern around congenital syphilis globally; however, little data are available regarding the burden of syphilis in pregnant women using PrEP and their infants in Africa. Per local standard of care, women were tested with an onsite rapid treponemal test to guide treatment, followed by laboratory testing (Treponema pallidum antibody test [TPHA] with rapid plasma reagin testing). Maternal and infant data were extracted from antenatal care files, neonatal clinical records, and National Health Laboratory Systems data. |
---|---|
ISSN: | 1473-3099 1474-4457 |
DOI: | 10.1016/S1473-3099(24)00259-7 |